from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3099c/-

LFCtreatmentdescriptionclass of inhibitor

-0.308

Amikacinug/mL Amikacintranslation

0.574

Cap5-10ug/mL Capreomycintranslation

0.572

Rox10-50 ug/mL Roxithromycintranslation

0.731

SM2-5 ug/mL Streptomycintranslation

-1.002

Tet5-10 ug/mL Tetracyclinetranslation

-0.780

Rif0.2-5ug/mL Rifampicintranscription

0.321

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.297

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.069

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.174

CPZ10-50 ug/mL Chlorpromazinerespiration

-2.717

Clofazimine10-13 ug/mL Clofaziminerespiration

0.649

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.171

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.781

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.149

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.751

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.468

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.670

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.449

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.494

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.149

KCN5-20 ug/mL Potassium cyaniderespiration

0.549

NaN30.2-2 mM Sodium aziderespiration

0.190

Nigericin50 uM Nigericinrespiration

-0.646

TRC10-150 ug/mL Triclosanrespiration

-0.918

TRZ10-25 ug/mL Thioridazinerespiration

-1.305

Valinomycin0.5-10 uM Valinomycinrespiration

-0.014

ZnSO42 mM ZnSO4respiration

-0.582

menadione6-10 ug/mL Menadionerespiration

0.046

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.858

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.477

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.741

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.759

NRP_1Non-replicating persistence stage 1dosRassociated

0.651

Amp0.2mg/mL AmpicillincellWall

0.212

Cephalexin20-100 ug/mL CephalexincellWall

0.376

Cerulenin0.32-5 ug/mL CerulenincellWall

0.367

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.062

EMB10-20 ug/mL EthambutolcellWall

0.786

Eta12-40 ug/mL EthionamidecellWall

0.432

INH0.2-0.4 ug/mL IsoniazidcellWall

0.541

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.681

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.397

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.143

BZA0.12 mg/mL BenzamidearomaticAmides

0.186

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.544

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.431

H2O24 mM hydrogen peroxideDNAdamaging

0.232

Levo10 ug/mL LevofloxacinDNAdamaging

-0.324

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.035

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.409

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.114

UVUV-irradiationDNAdamaging

-1.188

ARP41-4 ug/mL Antitubercular compound ARP4?

0.512

Antimycin12.5-50 ug/mL Antimycin A?

0.366

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.747

PA_110-50 ug/mL Antitubercular compound PA-1?

0.443

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.358

PA8240.2-2 ug/mL PA-824?

0.367

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.071

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.520

Verapamil50 uM Verapamil?

0.467

mercaptoethanol2 mM 2-Mercaptoethanol?

0.868

methoxatin10-20 ug/mL Methoxatin?